Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.8 |
mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.8 |
mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |